WILMINGTON, MA, –As it continues to increase the global reach of its explosives trace detection equipment, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has received the grant of a new patent by the Patent Office of the Russian Federation. The patent covers a method of increasing the amount of explosive materials collected from a surface using the Company’s patented non-contact vortex attractor technology.

“Our Quantum Sniffers(TM) detect a wide range of trace explosives without physical contact between the device and the inspected person or item. In addition to the benefits associated with protecting privacy in passenger screening, non-contact sample collection enables operational concepts that just aren’t possible using wipe techniques,” stated Todd Silvestri, Vice President of Technology at Implant Sciences. “With this patent, we are extending the intellectual property protection surrounding our innovative sampling technologies.”

Dr. William McGann, Implant Sciences’ COO, added, “I’m very proud of our technology team and their continued ability to innovate at a brisk pace. The advancements being made by our team are foundational for the next generation of explosives trace detection technology.”

According to a recent Frost & Sullivan report, the BRIC countries (Brazil, Russia, India, and China) together already account for 13% of global defense expenditures, making them the second largest consumer of defense goods and services in the world, after the United States. The report also quoted industry experts describing the BRIC countries as the hot spots for defense industries, stating that defense spending is expected to escalate at an accelerated pace compared to the rest of the world. The Quantum Sniffer QS-H150 was certified by the Russian Ministry of Transportation and deployed at Moscow’s Sheremetyevo International Airport in 2007.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company’s QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.